Fabros, Jullian Mae .

HRN: 26-87-76  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/29/2025
04/08/2025
IV
70mg
Q8h
AGE With Moderate Dehydration
Waiting Final Action 
04/01/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
04/01/2025
04/04/2025
ORAL
5ml
Q8
AGE
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: